tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market
HUMA
Humacyte
RESEARCH TOOLSreports
Want to see HUMA full AI Analyst Report?

Humacyte (HUMA) Stock News & Sentiment

1,663 Followers
Humacyte Earnings Call Balances Growth With Losses
Premium
Company Announcements
Humacyte Earnings Call Balances Growth With Losses
11d ago
HUMA
Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts
Premium
Ratings
Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts
11d ago
HUMA
Humacyte Receives Nasdaq Notice on Minimum Bid Requirement
Premium
Company Announcements
Humacyte Receives Nasdaq Notice on Minimum Bid Requirement
16d ago
8K
HUMA
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
Premium
Class Action
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
20d ago
HUMA
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
Premium
Ratings
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
26d ago
HUMA
Humacyte Regains Global Rights to Symvess Vascular Graft
Premium
Company Announcements
Humacyte Regains Global Rights to Symvess Vascular Graft
1M ago
8K
HUMA
Humacyte: Near-Term Commercial Headwinds but Platform Catalysts Support Long-Term Upside and Buy Rating
Premium
Ratings
Humacyte: Near-Term Commercial Headwinds but Platform Catalysts Support Long-Term Upside and Buy Rating
2M ago
HUMA
More HUMA News >

HUMA News on the Web

Largest borrow rate increases among liquid names
TipRanks News
Neutral
High-Profile Director Makes Bold Move Into Humacyte Shares
TipRanks News
Neutral
Humacyte reports Symvess under contract with Strategic Acquisition Center of VA
TipRanks News
Bullish
Humacyte price target raised to $1.50 from $1 at TD Cowen
TipRanks News
Bullish
Piper Sandler Keeps Their Hold Rating on Humacyte (HUMA)
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Cullinan Management (CGEM), Humacyte (HUMA) and Revvity (RVTY)
TipRanks News
Bullish
Humacyte (HUMA) Gets a Buy from Barclays
TipRanks News
Bullish
Humacyte Earnings Call Balances Growth With Losses
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
HUMA
Sector Average
Media Buzz
This Week3 articles
Weekly Average4.75 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HUMA’s Media Buzz Sentiment?
3 articles about HUMA were published this week. In an average week, 4.75 articles are published.
    What is HUMA’s weekly average amount of articles?
    In an average week, 4.75 articles about HUMA are published.
      What is HUMA’s News Sentiment?
      99% of articles about HUMA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week